Abstract
Lung surgery for non-small cell lung cancer (NSCLC) is currently based on anatomical pulmonary resections tailored to tumor size and tumor location in order to achieve a complete resection associated to a lymphadenectomy. Since the last guidelines of the French society of thoracic and cardiovascular surgery (FSTCVS) in 2009, we have faced the development of new surgical techniques of approaches and parenchymal resections. Surgical approaches are moving toward minimally invasive procedures especially for early stage tumors. These surgical approaches include video-assisted thoracic surgery (VATS), robotic-assisted thoracic surgery (RATS) and single-port surgery. Limited, so-called sublobar, resections (segmentectomy) have been revived from the old times of tuberculosis surgery, and are expected to increase with the high proportion of lung abnormalities detected with low-dose spiral computed tomography scan such as small nodules and ground glass opacities along with the implementation of screening programs. Conservative surgical resections (angio and/or bronchoplastic lobectomies) have been refined to allow avoidance of pneumonectomy. At last, benefits of a systematic lymphadenectomy compared to sampling have been put back into question in a subgroup of patients with early stage cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
